Intelligent Bio Solutions Stock Price Patterns
| INBS Stock | USD 4.89 0.13 2.73% |
Momentum 36
Sell Extended
Oversold | Overbought |
EPS Estimate Next Year 0.35 | Wall Street Target Price 12 | EPS Estimate Current Quarter (0.32) | Quarterly Revenue Growth 0.476 |
Using Intelligent Bio hype-based prediction, you can estimate the value of Intelligent Bio Solutions from the perspective of Intelligent Bio response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Intelligent Bio to buy its stock at a price that has no basis in reality. In that case, they are not buying Intelligent because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Intelligent Bio after-hype prediction price | USD 4.75 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Intelligent | Build AI portfolio with Intelligent Stock |
Intelligent Bio After-Hype Price Density Analysis
As far as predicting the price of Intelligent Bio at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Intelligent Bio or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Intelligent Bio, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Intelligent Bio Estimiated After-Hype Price Volatility
In the context of predicting Intelligent Bio's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Intelligent Bio's historical news coverage. Intelligent Bio's after-hype downside and upside margins for the prediction period are 0.24 and 24.99, respectively. We have considered Intelligent Bio's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Intelligent Bio is dangerous at this time. Analysis and calculation of next after-hype price of Intelligent Bio Solutions is based on 3 months time horizon.
Intelligent Bio Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Intelligent Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Intelligent Bio backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Intelligent Bio, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.77 | 20.24 | 2.21 | 0.47 | 8 Events / Month | 5 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
4.89 | 4.75 | 0.21 |
|
Intelligent Bio Hype Timeline
Intelligent Bio Solutions is currently traded for 4.89. The entity has historical hype elasticity of 2.21, and average elasticity to hype of competition of -0.47. Intelligent is forecasted to decline in value after the next headline, with the price expected to drop to 4.75. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.21%, whereas the daily expected return is currently at 0.77%. The volatility of related hype on Intelligent Bio is about 3328.95%, with the expected price after the next announcement by competition of 4.42. The company has price-to-book (P/B) ratio of 1.65. Some equities with similar Price to Book (P/B) outperform the market in the long run. Intelligent Bio Solutions recorded a loss per share of 14.45. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 16th of December 2025. Given the investment horizon of 90 days the next forecasted press release will be in about 8 days. Check out Intelligent Bio Basic Forecasting Models to cross-verify your projections.Intelligent Bio Related Hype Analysis
Having access to credible news sources related to Intelligent Bio's direct competition is more important than ever and may enhance your ability to predict Intelligent Bio's future price movements. Getting to know how Intelligent Bio's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Intelligent Bio may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| MYNZ | Mainz Biomed BV | (0.02) | 5 per month | 0.00 | (0.20) | 9.48 | (8.82) | 29.95 | |
| CHEK | Check Cap | (0.01) | 17 per month | 6.07 | 0.12 | 17.16 | (10.37) | 198.26 | |
| PAVM | PAVmed Inc | (5.94) | 7 per month | 7.20 | 0.03 | 11.52 | (9.52) | 111.24 | |
| MTNB | Matinas BioPharma Holdings | (0.04) | 4 per month | 0.00 | (0.10) | 11.67 | (10.45) | 32.48 | |
| HSCS | Heart Test Laboratories | (0.18) | 9 per month | 4.86 | 0 | 11.07 | (7.86) | 21.61 | |
| SSKN | STRATA Skin Sciences | (0.09) | 7 per month | 0.00 | (0.22) | 7.56 | (10.26) | 78.88 | |
| BNGO | Bionano Genomics | (0.01) | 8 per month | 0.00 | (0.10) | 4.61 | (5.51) | 21.29 | |
| BCLI | Brainstorm Cell Therapeutics | (0.01) | 5 per month | 0.00 | (0.03) | 10.91 | (7.02) | 24.01 | |
| POAI | Predictive Oncology | (0.03) | 20 per month | 0.00 | (0.08) | 15.02 | (19.12) | 77.03 | |
| ADIL | Adial Pharmaceuticals | 0.25 | 8 per month | 0.00 | (0.35) | 5.70 | (8.24) | 34.48 |
Intelligent Bio Additional Predictive Modules
Most predictive techniques to examine Intelligent price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Intelligent using various technical indicators. When you analyze Intelligent charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Intelligent Bio Predictive Indicators
The successful prediction of Intelligent Bio stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Intelligent Bio Solutions, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Intelligent Bio based on analysis of Intelligent Bio hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Intelligent Bio's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Intelligent Bio's related companies. | 2023 | 2024 | 2025 | 2026 (projected) | Interest Debt Per Share | 0.42 | 0.065 | 0.0747 | 0.071 | Revenue Per Share | 1.87 | 0.58 | 0.52 | 0.62 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Intelligent Stock Analysis
When running Intelligent Bio's price analysis, check to measure Intelligent Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelligent Bio is operating at the current time. Most of Intelligent Bio's value examination focuses on studying past and present price action to predict the probability of Intelligent Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelligent Bio's price. Additionally, you may evaluate how the addition of Intelligent Bio to your portfolios can decrease your overall portfolio volatility.